Pacira Biosciences

World Rank (Jan-05-2024)

6,744

Market Cap (Jan-05-2024)

1.506 Billion USD

World Rank (Jul-30-2023)

6,485

Market Cap (Jul-30-2023)

1.645 Billion USD

World Rank (Jan-07-2022)

5,267

Market Cap (Jan-07-2022)

2.674 Billion USD

World Rank (Jan-01-2021)

4,687

Market Cap (Jan-01-2021)

2.600 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

PCRX

Market Cap (Mar-08-2026)

0.89

Employee Count

697

Employee Count as of Date

As on 2021

Headquarters City/State

New Jersey

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

666 Million USD

Annual Operating Income in USD

71 Million USD

Annual Net Income in USD

16 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

1,681 Million USD

Total Liabilities in USD

906 Million USD

Total Equity in USD

775 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Company Website

Yahoo

Company Profile

Pacira BioSciences is a Pharmaceutical company. It is the organization built on high ethical standards an unwavering commitment to patients and transparent communications and have a drive and a desire to improve the world around and make a meaningful difference in the lives of patients, families, communities and society. The headquarters is in USA.

Founded Year

2006

IPO Year

2011

Stock Exchange

Frankfurt

Nasdaq

Company SubCategory

Top Healthcare Companies in USA

Nasdaq Sector

Health Care

Nasdaq Industry